Combined Pneumococcal Conjugate and Polysaccharide Vaccination in Inflammatory Rheumatic Disease

PHASE4CompletedINTERVENTIONAL

Enrollment

300

Participants

Timeline

Start Date

June 14, 2016

Primary Completion Date

September 3, 2018

Study Completion Date

December 21, 2020

Conditions

Rheumatoid ArthritisSystemic LupusSjögren SyndromeSystemic VasculitisSpondyloarthritis

Interventions

BIOLOGICAL

13-valent pneumococcal conjugate vaccine

Pneumococcal conjugate vaccination during antirheumatic treatment

BIOLOGICAL

23-valent pneumococcal polysaccharide vaccine

Pneumococcal polysaccharide vaccination during antirheumatic treatment

All Listed Sponsors

lead

Region Skane

OTHER

NCT03762824 - Combined Pneumococcal Conjugate and Polysaccharide Vaccination in Inflammatory Rheumatic Disease | Biotech Hunter | Biotech Hunter